Physician

Mateo Mejia Saldarriaga, M.D

According to 2025 Medicare claims, Mateo Saldarriaga, M.D (NPI: 1417400540) practices medical oncology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from New York, NY. This provider's primary affiliated billing organization is WEILL MEDICAL COLLEGE OF CORNELL (NPI: 1770892580; TIN: 131623978) and primary practice location at 10065-8722. Saldarriaga is affiliated with the NewYork Quality Care (ACO ID: A2571), participating under the MSSP model.

Saldarriaga's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 271 traditional Medicare patients, billed 71,185 HCPCS/CPT codes, and received $2,111,181 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 112 prescription claims across 30 beneficiaries totaling $121,866 in drug costs, led by Valacyclovir (Valacyclovir Hcl). Open Payments data shows 9 records totaling $950. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $4,966 and ending at $121,866. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.1M2023 Medicare payment: $308,382 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,111,181 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
20237012,104$308,382
202427171,185$2,111,181

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$240K$480K2016 Drug cost: $4,966 (USD; Tot_Drug_Cst)2017 Drug cost: $21,779 (USD; Tot_Drug_Cst)2018 Drug cost: $36,060 (USD; Tot_Drug_Cst)2019 Drug cost: $40,032 (USD; Tot_Drug_Cst)2020 Drug cost: $24,489 (USD; Tot_Drug_Cst)2021 Drug cost: $479,772 (USD; Tot_Drug_Cst)2022 Drug cost: $10,549 (USD; Tot_Drug_Cst)2023 Drug cost: $3,142 (USD; Tot_Drug_Cst)2024 Drug cost: $121,866 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/R41$4,966
201739321$21,779
201837628$36,060
201938415$40,032
20201437$24,489
202130114$479,772
202243124$10,549
20232270$3,142
202430112$121,866

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more4646$192
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more116266$155
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4770$105
99233Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes89338$103
36415Insertion of needle into vein for collection of blood sample145376$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ValacyclovirValacyclovir Hcl311,650$1,416

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.9$950Janssen Scientific Affairs, LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mateo Mejia Saldarriaga, M.D?

Tedicare shows public-source Medicare data for Mateo Mejia Saldarriaga, M.D (NPI 1417400540), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mateo Mejia Saldarriaga, M.D have ACO affiliation data?

Mateo Mejia Saldarriaga, M.D is shown with ACO affiliation data for NewYork Quality Care (MSSP, ACO ID A2571).

What billing organization is linked to Mateo Mejia Saldarriaga, M.D?

Mateo Mejia Saldarriaga, M.D is linked to WEILL MEDICAL COLLEGE OF CORNELL (billing NPI 1770892580) in the available physician profile data.

Does Mateo Mejia Saldarriaga, M.D have Open Payments data?

Mateo Mejia Saldarriaga, M.D has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.